Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rubin

Showing results (1111-1120 of 1,202) with videos related to

Pageof 121
Sort By:
Plos Medicine|April 2, 2025
Predatory journals: What can we do to protect their prey?Christine Laine, Dianne Babski, Vivienne C Bachelet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancerM J O'Connell, J A Laurie, M Kahn, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
Engineering SIRPα conformational plasticity to reveal a cryptic pocket suitable for structure-based drug designM Storder, S Barelier, F Cordier, et al.
The Journal of Rheumatology|October 4, 2011
Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Otylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Molecular Microbiology|December 18, 2018
Inhibition of Pseudomonas aeruginosa and Mycobacterium tuberculosis disulfide bond forming enzymesCristina Landeta, Laura McPartland, Ngoc Q Tran, et al.
European Journal of Heart Failure|January 12, 2019
Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON studyMaurice Beghetti, Richard N Channick, Kelly M Chin, et al.
Clinical and Experimental Rheumatology|June 26, 2010
Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosisDoerte Huscher, David Pittrow, Oliver Distler, et al.
The Journal of Rheumatology|December 4, 2009
Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS groupOtylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Cell|December 25, 2018
Coupled Single-Cell CRISPR Screening and Epigenomic Profiling Reveals Causal Gene Regulatory NetworksAdam J Rubin, Kevin R Parker, Ansuman T Satpathy, et al.
Chest|July 12, 2016
Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH TrialRobert C Bourge, Aaron B Waxman, Mardi Gomberg-Maitland, et al.
Pageof 121

Showing results (1111-1120 of 1,202) with videos related to

Sort By:
Pageof 121
Plos Medicine|April 2, 2025
Predatory journals: What can we do to protect their prey?Christine Laine, Dianne Babski, Vivienne C Bachelet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancerM J O'Connell, J A Laurie, M Kahn, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
Engineering SIRPα conformational plasticity to reveal a cryptic pocket suitable for structure-based drug designM Storder, S Barelier, F Cordier, et al.
The Journal of Rheumatology|October 4, 2011
Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Otylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Molecular Microbiology|December 18, 2018
Inhibition of Pseudomonas aeruginosa and Mycobacterium tuberculosis disulfide bond forming enzymesCristina Landeta, Laura McPartland, Ngoc Q Tran, et al.
European Journal of Heart Failure|January 12, 2019
Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON studyMaurice Beghetti, Richard N Channick, Kelly M Chin, et al.
Clinical and Experimental Rheumatology|June 26, 2010
Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosisDoerte Huscher, David Pittrow, Oliver Distler, et al.
The Journal of Rheumatology|December 4, 2009
Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension: a systematic literature analysis by the EPOSS groupOtylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Cell|December 25, 2018
Coupled Single-Cell CRISPR Screening and Epigenomic Profiling Reveals Causal Gene Regulatory NetworksAdam J Rubin, Kevin R Parker, Ansuman T Satpathy, et al.
Chest|July 12, 2016
Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH TrialRobert C Bourge, Aaron B Waxman, Mardi Gomberg-Maitland, et al.
Pageof 121